Form D · Pharmaceuticals
Accu-Break Pharmaceuticals, Inc.
Hollywood, FL · CIK 0001398554
Offering snapshot reported Jun 2, 2015 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 29, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2015 | Initial | $500,000 | No comparison | 7 | SEC filing |
| May 20, 2013 | Initial | $1,000,000 | No comparison | 14 | SEC filing |
| Apr 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240947
Source: Form D, filed Jun 2, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert E. Baldini | Director |
| Robert I. Goldfarb | Executive |
| Elliot F. Hahn | Director, Executive |
| Mel Harris | Director |
| David Lucking | Director |
| Lloyd A. Moriber | Director |
| Nigel N. Norton | Director |
| John M. Siebert | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6100 Hollywood Boulevard Suite 307
Hollywood, FL, 33024
Hollywood, FL, 33024